Radiation-Sensitizing Agents
"Radiation-Sensitizing Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Drugs used to potentiate the effectiveness of radiation therapy in destroying unwanted cells.
| Descriptor ID |
D011838
|
| MeSH Number(s) |
D27.505.954.600
|
| Concept/Terms |
Radiation-Sensitizing Agents- Radiation-Sensitizing Agents
- Radiation Sensitizers
- Sensitizers, Radiation
- Radiation Sensitizing Agents
- Sensitizing Agents, Radiation
- Radiosensitizing Agents
- Agents, Radiosensitizing
- Radiosensitizing Drugs
- Drugs, Radiosensitizing
- Agents, Radiation-Sensitizing
- Agents, Radiation Sensitizing
- Radiation-Sensitizing Drugs
- Drugs, Radiation-Sensitizing
- Radiation Sensitizing Drugs
Radiation-Sensitizing Effect- Radiation-Sensitizing Effect
- Effect, Radiation-Sensitizing
- Radiation Sensitizing Effect
- Radiosensitizing Effect
- Effect, Radiosensitizing
- Radiosensitizing Effects
- Effects, Radiosensitizing
- Radiation-Sensitizing Effects
- Effects, Radiation-Sensitizing
- Radiation Sensitizing Effects
|
Below are MeSH descriptors whose meaning is more general than "Radiation-Sensitizing Agents".
Below are MeSH descriptors whose meaning is more specific than "Radiation-Sensitizing Agents".
This graph shows the total number of publications written about "Radiation-Sensitizing Agents" by people in this website by year, and whether "Radiation-Sensitizing Agents" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2006 | 0 | 1 | 1 |
| 2012 | 1 | 0 | 1 |
| 2014 | 1 | 0 | 1 |
| 2015 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Radiation-Sensitizing Agents" by people in Profiles.
-
A patient-specific computational model of hypoxia-modulated radiation resistance in glioblastoma using 18F-FMISO-PET. J R Soc Interface. 2015 Feb 06; 12(103).
-
Radiosensitizing effect of anti-HER2/neu agents: Report of 2 cases and review of the literature. Pract Radiat Oncol. 2015 Mar-Apr; 5(2):e61-5.
-
Prognostic significance of carbohydrate antigen 19-9 in unresectable locally advanced pancreatic cancer treated with dose-escalated intensity modulated radiation therapy and concurrent full-dose gemcitabine: analysis of a prospective phase 1/2 dose escalation study. Int J Radiat Oncol Biol Phys. 2013 May 01; 86(1):96-101.
-
A phase I dose escalation study of Ad GV.EGR.TNF.11D (TNFerade? Biologic) with concurrent chemoradiotherapy in patients with recurrent head and neck cancer undergoing reirradiation. Ann Oncol. 2013 Mar; 24(3):769-76.
-
A phase I/II trial of intensity modulated radiation (IMRT) dose escalation with concurrent fixed-dose rate gemcitabine (FDR-G) in patients with unresectable pancreatic cancer. Int J Radiat Oncol Biol Phys. 2012 Dec 01; 84(5):1166-71.
-
The role of emerging and investigational therapies for metastatic brain tumors: a systematic review and evidence-based clinical practice guideline of selected topics. J Neurooncol. 2010 Jan; 96(1):115-42.
-
The pleiotropic effects of ethacrynic acid. Am J Ther. 2009 Jan-Feb; 16(1):102-4.
-
Intrinsic radiation resistance in human chondrosarcoma cells. Biochem Biophys Res Commun. 2006 Jul 28; 346(2):379-85.
-
Adjuvant therapy for pancreatic cancer: back to the future. Int J Radiat Oncol Biol Phys. 1998 Aug 01; 42(1):59-63.
-
Treatment of 29 patients with bulky squamous cell carcinoma of the cervix with simultaneous cisplatin, 5-fluorouracil, and split-course hyperfractionated radiation therapy. Gynecol Oncol. 1990 Sep; 38(3):323-7.